Corrigendum to "Inhibition of the ʟ-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors" [Canc. Lett. 507 (2021) 13-25]
Cancer Lett. 2022 Feb 1:526:363.
doi: 10.1016/j.canlet.2021.11.029.
Epub 2021 Dec 4.
1 Laboratory of Experimental Medicine, Centre of New Technologies, University of Warsaw, Poland; Postgraduate School of Molecular Medicine, Medical University of Warsaw, Poland. Electronic address: m.prelowska@cent.uw.edu.pl.
2 Laboratory of Experimental Medicine, Centre of New Technologies, University of Warsaw, Poland; Doctoral School of Medical University of Warsaw, Warsaw, Poland; Laboratory of Centre for Preclinical Research, Department of Methodology, Medical University of Warsaw, Warsaw, Poland; Laboratory of Experimental Medicine, Medical University of Warsaw, Poland.
3 Laboratory of Experimental Medicine, Centre of New Technologies, University of Warsaw, Poland.
4 Laboratory of Experimental Medicine, Centre of New Technologies, University of Warsaw, Poland; Laboratory of Experimental Medicine, Medical University of Warsaw, Poland. Electronic address: dominika.nowis@wum.edu.pl.